WB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated THP-1 whole cell lysate 20 µg
Lane 2: THP-1 treated with 50 nM PMA and 5 µg/ml LPS for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 110 kDa
Product Details
Product Details
Product Specification
Host | Rabbit |
Antigen | Rig-I/DDX58 |
Synonyms | Antiviral innate immune response receptor RIG-I; ATP-dependent RNA helicase DDX58; DEAD box protein 58; RIG-I-like receptor 1 (RLR-1); RNA sensor RIG-I; Retinoic acid-inducible gene 1 protein (RIG-1); Retinoic acid-inducible gene I protein (RIG-I); DDX58; RIGI |
Immunogen | Synthetic Peptide |
Location | Cytoplasm, Cell junction |
Accession | O95786 |
Clone Number | S-1419-114 |
Antibody Type | Recombinant mAb |
Isotype | IgG |
Application | WB |
Reactivity | Hu, Ms |
Purification | Protein A |
Concentration | 0.5 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application | dilution | species |
WB | 1:1000 | Hu, Ms |
Background
Rig-I (Retinoic acid-inducible gene I) is a crucial cytosolic pattern recognition receptor (PRR) in the innate immune system, belonging to the DExD/H-box RNA helicase family. It primarily detects viral RNA, such as short double-stranded RNA (dsRNA) with a 5'-triphosphate group (5'-ppp) or single-stranded RNA (ssRNA) with short stem-loop structures, thereby triggering antiviral immune responses. Structurally, Rig-I consists of two N-terminal tandem CARD domains (for signal transduction), a central DExD/H-box helicase domain (responsible for RNA binding and ATP hydrolysis), and a C-terminal regulatory domain (CTD, which specifically recognizes viral RNA). Upon binding viral RNA, Rig-I interacts with the mitochondrial antiviral signaling protein (MAVS) via its CARD domains, activating the IRF3/7 and NF-κB pathways to induce the production of type I interferons and pro-inflammatory cytokines. This protein plays a central role in defending against RNA viruses (e.g., influenza virus, hepatitis C virus), and its dysfunction is closely associated with autoimmune diseases and increased susceptibility to viral infections.
Picture
Picture
Western Blot
WB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated RAW264.7 whole cell lysate 20 µg
Lane 2: RAW264.7 treated with 0.1 µg/ml LPS for 6 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 115 kDa
